Pajzsmirigyrák: vizsgálatok itt: Japán
5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Kanagawa, Kyoto, Tokyo
- Életkor
- 18 év and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - 1. fázisTaking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Chuo Ku
- Életkor
- 18 év to 100 év
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - 2. fázisNot yet taking people in JapánSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
- Where
- Tokyo
- Életkor
- 18 év to 99 év
- People
- 68 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07521670 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 1. fázisTaking peopleA Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 38
- Run by
- Alpha Fusion Inc.
See details and how to joinNCT07287748